{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:02:22Z","timestamp":1753891342763,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med. Technol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Ghrelin is an orexigenic peptide that becomes post-translationally modified. Natural autoantibodies to ghrelin (ghrelin-aAb) have been described in healthy subjects, in eating disorders and rheumatic diseases, with potential clinical relevance. Despite these important reports, the data base on the prevalence and physiological role is small and technical approaches for assessing ghrelin-aAb are few, encouraging respective research for improving knowledge on the potential endocrine significance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A novel immunoprecipitation assay was generated based on a fusion protein of human ghrelin with a reporter gene. Assay quality was verified with commercial antibodies. Assay characteristics and matrix effects were determined, including stability of natural ghrelin-aAb to freezing, signal linearity in dilution experiments, and comparison of different matrices. Three groups of serum samples were analyzed for ghrelin-aAb, comprising commercial sera from healthy subjects and patients with type 1 or type 2 diabetes mellitus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The newly generated ghrelin-aAb assay proved sensitive, robust and reliable over a broad concentration range. Results from serum and plasma differed slightly. The signals from serum remained stable towards freezing and thawing, and in dilution experiments. Applying a mathematical criterion for outliers (P75\u2009+\u20091.5-times IQR), an average prevalence of 11%\u201312% of positive samples was identified in the different human cohorts, with no significant sex-or disease-related difference.<\/jats:p><\/jats:sec><jats:sec><jats:title>General significance<\/jats:title><jats:p>A novel diagnostic autoantibody assay detected ghrelin-aAb with a similar prevalence in diabetic patients and controls, suggesting that autoimmunity to ghrelin plays little role in diabetes mellitus, but may be of relevance in other diseases where ghrelin signaling is essential.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmedt.2024.1407409","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:45:44Z","timestamp":1720759544000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Detection of natural autoimmunity to ghrelin in diabetes mellitus"],"prefix":"10.3389","volume":"6","author":[{"given":"Rega H.","family":"Kasim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo Samson","family":"Chillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Eleftheriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Rijntjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar B.","family":"Minich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zechmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Schomburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"B1","first-page":"5","article-title":"Neuro-hormonal control of food intake: basic mechanisms and clinical implications","volume":"56","author":"Konturek","year":"2005","journal-title":"J Physiol Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fendo.2014.00058","article-title":"Peptides and food intake","volume":"5","author":"Crespo C","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.peptides.2011.07.021","article-title":"Ghrelin and appetite control in humans\u2013potential application in the treatment of obesity","volume":"32","author":"Patterson","year":"2011","journal-title":"Peptides"},{"key":"B4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/MCO.0b013e328365b9be","article-title":"Ghrelin: much more than a hunger hormone","volume":"16","author":"Pradhan","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1111\/febs.15718","article-title":"The ups and downs of growth hormone secretagogue receptor signaling","volume":"288","author":"Cornejo","year":"2021","journal-title":"Febs j"},{"key":"B6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","article-title":"Ghrelin regulation of glucose metabolism","volume":"100","author":"Poher","year":"2018","journal-title":"Peptides"},{"key":"B7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tsch\u00f6p","year":"2000","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.2337\/diabetes.52.10.2546","article-title":"Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes","volume":"52","author":"P\u00f6ykk\u00f6","year":"2003","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s13105-022-00933-1","article-title":"Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression","volume":"79","author":"Tuero","year":"2023","journal-title":"J Physiol Biochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1210\/jc.2018-01171","article-title":"Ghrelin reduces TNF-\u03b1-induced human hepatocyte apoptosis, autophagy, and pyroptosis: role in obesity-associated NAFLD","volume":"104","author":"Ezquerro","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.advnut.2023.07.011","article-title":"Endogenous ghrelin levels and perception of hunger: a systematic review and meta-analysis","volume":"14","author":"Anderson","year":"2023","journal-title":"Adv Nutr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/DMSO.S393373","article-title":"Leu72Met polymorphism in ghrelin gene: a potential risk factor for hypertension in type 2 diabetes patients","volume":"16","author":"Buraczynska","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1111\/acer.14967","article-title":"Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: a narrative review","volume":"46","author":"Kharbanda","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"105685","DOI":"10.1016\/j.appet.2021.105685","article-title":"IgG antibodies reacting with ghrelin and leptin are correlated with body composition and appetitive traits in young subjects","volume":"168","author":"Espinoza-Garc\u00eda","year":"2022","journal-title":"Appetite"},{"key":"B15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.nut.2008.06.021","article-title":"Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders","volume":"24","author":"Fetissov","year":"2008","journal-title":"Nutrition"},{"key":"B16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.nut.2011.01.002","article-title":"Ghrelin reactive autoantibodies in restrictive anorexia nervosa","volume":"27","author":"Terashi","year":"2011","journal-title":"Nutrition"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2017.00010","article-title":"Ghrelin-Reactive immunoglobulins in conditions of altered appetite and energy balance","volume":"8","author":"Fetissov","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"613983","DOI":"10.3389\/fendo.2021.613983","article-title":"Current aspects of the role of autoantibodies directed against appetite-regulating hormones and the gut microbiome in eating disorders","volume":"12","author":"Smitka","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fendo.2019.00252","article-title":"IgG anti-ghrelin immune complexes are increased in rheumatoid arthritis patients under biologic therapy and are related to clinical and metabolic markers","volume":"10","author":"Porchas-Quijada","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1038\/ncomms3685","article-title":"Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans","volume":"4","author":"Takagi","year":"2013","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2014.12.011","article-title":"Ghrelin-reactive immunoglobulins and anxiety, depression and stress-induced cortisol response in adolescents. The TRAILS study","volume":"59","author":"Fran\u00e7ois","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313088","article-title":"Natural autoimmunity to selenoprotein P impairs selenium transport in hashimoto\u2019s thyroiditis","volume":"22","author":"Sun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbacli.2016.08.001","article-title":"Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients","volume":"6","author":"Schuette","year":"2016","journal-title":"BBA Clin"},{"key":"B24","doi-asserted-by":"publisher","first-page":"831641","DOI":"10.3389\/fphys.2022.831641","article-title":"Acylation, a conductor of ghrelin function in brain health and disease","volume":"13","author":"Thomas","year":"2022","journal-title":"Front Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"210080","DOI":"10.1098\/rsob.210080","article-title":"Ghrelin octanoylation by ghrelin O-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling","volume":"11","author":"Davis","year":"2021","journal-title":"Open Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/bios13030303","article-title":"Advancing luciferase-based antibody immunoassays to next-generation mix and read testing","volume":"13","author":"Burbelo","year":"2023","journal-title":"Biosensors (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.31138\/mjr.30.1.26","article-title":"Certified reference materials and their need for the diagnosis of autoimmune diseases","volume":"30","author":"Monogioudi","year":"2019","journal-title":"Mediterr J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jim.2019.03.011","article-title":"ELISA methods comparison for the detection of auto-antibodies against apolipoprotein A1","volume":"469","author":"Frias","year":"2019","journal-title":"J Immunol Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s40519-022-01388-5","article-title":"Anti-hypothalamus autoantibodies in anorexia nervosa: a possible new mechanism in neuro-physiological derangement?","volume":"27","author":"Escelsior","year":"2022","journal-title":"Eat Weight Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mam.2012.10.005","article-title":"Obesity pharmacotherapy: what is next?","volume":"34","author":"Colon-Gonzalez","year":"2013","journal-title":"Mol Aspects Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/ITT.S60398","article-title":"Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy","volume":"4","author":"Altabas","year":"2015","journal-title":"Immunotargets Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1771","article-title":"Autoantibodies to the IGF1 receptor in graves\u2019 orbitopathy","author":"Minich","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0566","article-title":"Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease","author":"Eleftheriadou","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1210\/clinem\/dgad125","article-title":"A novel in vitro assay correlates insulin receptor autoantibodies with fasting insulin in type B insulin resistance","volume":"108","author":"Minich","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s13300-023-01416-2","article-title":"Optimizing multidisciplinary care of patients with chronic kidney disease and type 2 diabetes Mellitus","volume":"14","author":"Kelepouris","year":"2023","journal-title":"Diabetes Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller","year":"2015","journal-title":"Mol Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"101175","DOI":"10.1016\/j.molmet.2021.101175","article-title":"The gut-brain axis: identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders","volume":"46","author":"Richards","year":"2021","journal-title":"Mol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/nu15183960","article-title":"Ghrelin as a biomarker of \u201cimmunometabolic depression\u201d and its connection with dysbiosis","volume":"15","author":"Gajewska","year":"2023","journal-title":"Nutrients"}],"container-title":["Frontiers in Medical Technology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmedt.2024.1407409\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:45:46Z","timestamp":1720759546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmedt.2024.1407409\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":40,"alternative-id":["10.3389\/fmedt.2024.1407409"],"URL":"https:\/\/doi.org\/10.3389\/fmedt.2024.1407409","relation":{},"ISSN":["2673-3129"],"issn-type":[{"type":"electronic","value":"2673-3129"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"article-number":"1407409"}}